Bain Linda 4
4 · Codiak BioSciences, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
Bain Linda
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-16+7,613→ 15,982 total - Sale
Common Stock
2023-02-17$0.59/sh−2,570$1,522→ 13,412 total - Exercise/Conversion
Restricted Stock Units
2022-08-16−7,613→ 22,837 total→ Common Stock (7,613 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-16−7,613→ 15,224 total→ Common Stock (7,613 underlying) - Exercise/Conversion
Common Stock
2022-08-16+7,613→ 10,733 total - Sale
Common Stock
2022-08-17$2.21/sh−2,364$5,231→ 8,369 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On February 16, 2022, the reporting person was granted 30,450 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.